These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 17647191)
1. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191 [TBL] [Abstract][Full Text] [Related]
2. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma]. Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990 [TBL] [Abstract][Full Text] [Related]
5. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related]
6. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184 [TBL] [Abstract][Full Text] [Related]
7. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Shang X; Lin X; Alvarez E; Manorek G; Howell SB Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631 [TBL] [Abstract][Full Text] [Related]
8. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Turunen M; Talvensaari-Mattila A; Soini Y; Santala M Anticancer Res; 2009 Dec; 29(12):5185-9. PubMed ID: 20044634 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants. Aravindakshan J; Chen X; Sairam MR Neoplasia; 2006 Dec; 8(12):984-94. PubMed ID: 17217615 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of DEK overexpression in serous ovarian tumors. Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407 [TBL] [Abstract][Full Text] [Related]
11. [Expression of folate receptor alpha in ovarian epithelial tumors]. Shen DH; Xie JL; Zhang YL; Wang Y Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma. Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862 [TBL] [Abstract][Full Text] [Related]
13. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor. Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472 [TBL] [Abstract][Full Text] [Related]
14. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors. Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823 [TBL] [Abstract][Full Text] [Related]
15. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma. Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166 [TBL] [Abstract][Full Text] [Related]
18. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors. Lohneis P; Darb-Esfahani S; Dietel M; Braicu I; Sehouli J; Arsenic R Anticancer Res; 2015 Nov; 35(11):6329-34. PubMed ID: 26504072 [TBL] [Abstract][Full Text] [Related]
19. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. Shang X; Lin X; Manorek G; Howell SB Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]